HCR 553 Module 1 Module 1 Assignment: SOP Breakdown Example

Breaking Down an SOP: How a Site's Informed Consent Procedure Builds Quality Into Every Step

Student Name

MS in Clinical Research Management, Arizona State University

HCR 553: Quality Assurance and Clinical Research

Instructor Name

Month Day, Year

Breaking Down an SOP: How a Site's Informed Consent Procedure Builds Quality Into Every Step

Introduction

A standard operating procedure (SOP) is a written instruction that makes a task happen the same way every time, whoever does it. Good clinical practice expects sponsors and sites to work from SOPs so that quality is designed into routine work rather than inspected afterward (U.S. Food and Drug Administration, 2025). Informed consent is a good SOP to study because it is required by regulation, done many times at every site and a frequent source of inspection findings. This paper breaks down a research site's consent SOP into its parts, in the order the course workbook uses for site documents (Shah et al., 2017), and explains the quality purpose of each.

The SOP at a Glance

Breaking Down the Components

Header and Revision Control

The header's version number and effective date let anyone confirm they are using the current procedure, and approval signatures show who is accountable for it. Revision control matters because an outdated SOP is a quality risk in itself.

Purpose and Scope

The purpose states the outcome the SOP protects, voluntary and informed participation, and the scope states where it applies. Here the scope excludes participants who need a legally authorized representative, which means the site needs a second SOP for that situation.

Responsibilities

Naming roles turns a regulation into assigned work. The principal investigator remains responsible for consent even when delegating it, and only staff listed on the delegation log and trained on the protocol may obtain consent.

Procedure

The twelve steps include confirming the IRB-approved version of the form, allowing time to read and ask questions, checking understanding with open questions, obtaining signature and date before any study procedure, giving the participant a copy and documenting the process in a consent note. Each maps to a regulatory requirement. The federal rules list the elements every consent must contain and require written documentation on an IRB-approved form, with a copy given to the person signing (21 C.F.R. § 50.25; 21 C.F.R. § 50.27).

Documentation

The consent note records who obtained consent, when, which version, that questions were answered and that consent came before procedures. Inspectors look for exactly these facts, so the note is the evidence that the procedure was followed.

How the SOP Supports Quality Execution

Gaps and Recommendations

Two gaps would weaken quality. First, the SOP has no step for re-consent when the form is revised mid-study, so participants may not learn of new risks. Second, it does not address participants with limited English proficiency, though the federal rules require consent information in language understandable to the participant. Adding a re-consent procedure and a reference to a short-form or translated-consent SOP would close both gaps.

Conclusion

Breaking down a consent SOP shows how each part, from the version number to the consent note, protects a participant's right and gives the site evidence that it did so. An SOP is only as strong as its scope and its updates, which is why the breakdown ends with gaps rather than praise.

References

Documentation of informed consent, 21 C.F.R. § 50.27 (2025).

Elements of informed consent, 21 C.F.R. § 50.25 (2025).

Shah, K., Wells, C., & Pfeiffer, J. (2017). A clinical trial workbook: Material to complement research education and training (2nd ed.). LAD Custom Publishing.

U.S. Food and Drug Administration. (2025). E6(R3) good clinical practice (GCP) [Guidance for industry]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r3-good-clinical-practice-gcp